Skip to main content
Premium Trial:

Request an Annual Quote

RT-PCR HIV-1 Diagnostic by Abbott and Celera Gets CE Mark

NEW YORK, June 16 (GenomeWeb News) - An Abbott and Celera Diagnostics HIV-1 viral-load test has been awarded the European Union's CE Mark certification, the companies said today in a statement.


The CE Mark allows the companies to sell the PCR-based RealTime HIV-1 assay in the 25 member states of the European Union under the In Vitro Diagnostics Directive, the companies said.


The HIV-1 assay runs on Abbott's m2000 real-time PCR system. Abbot said it is also developing methods for detecting hepatitis C, hepatitis B, chlamydia, and gonorrhea that will run on the m2000 system.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.